The bill establishes a new section in Florida law, specifically section 381.73531, which focuses on obesity treatment and diabetes prevention. It mandates the Agency for Health Care Administration to provide coverage for various treatments related to obesity, including intensive health behavior and lifestyle treatment, metabolic and bariatric surgery, and FDA-approved obesity medications. The bill outlines definitions for key terms such as "diabetes prevention program," "FDA-approved obesity medication," and "intensive health behavior and lifestyle treatment." It also stipulates that coverage criteria for obesity medications cannot be more restrictive than FDA-approved indications and allows for the use of telehealth in delivering these services.

Additionally, the bill requires the agency to cover the diabetes prevention program, with Medicaid reimbursement for eligible enrollees starting July 1, 2025. To qualify for reimbursement, enrollees must meet specific eligibility requirements and have not previously participated in the program while enrolled in Medicaid. The Department of Health is authorized to apply for a state plan amendment if necessary to implement these provisions. The act is set to take effect on July 1, 2025.